Forecast & Rating3 analysts currently cover Cue BioPharma, of which 3 give a positive rating. The average price target is $88.00, about 177.5% upside from the current price of $31.71. Coverage is limited, so the data is for reference only. Data as of Sep 22, 2026; this does not constitute investment advice.
Sep 22, 2026Price forecast
$88.00177.51%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met0.0%
Stock price$31.71
Avg. target$88.0
High target$115
Low target$66
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.